TY - GEN AU - Maria Gruenberg AU - Clara Antunes Moniz AU - Natalie Ellen Hofmann AU - Rahel Wampfler AU - Cristian Koepfli AU - Ivo Mueller AU - Wuelton Marcelo Monteiro AU - Marcus Lacerda AU - Gisely Cardoso de Melo AU - Andrea Kuehn AU - Andre M Siqueira AU - Ingrid Felger TI - Plasmodium vivax molecular diagnostics in community surveys: pitfalls and solutions. PY - 2018/// CY - [Place of publication not identified] PB - BMC KW - Mitochondrial DNA KW - Surveillance KW - Plasmodium vivax KW - Quantification KW - LAMP KW - Molecular Diagnostics KW - B. Sc. Medical Laboratory Science KW - UMUN open access collection KW - molecular diagnostics KW - Review articles N1 - Publication type: Review article; Linked open-access copy: published version; Open access; no subscription required for the linked open-access version N2 - A distinctive feature of Plasmodium vivax infections is the overall low parasite density in peripheral blood. Thus, identifying asymptomatic infected individuals in endemic communities requires diagnostic tests with high sensitivity. The detection limits of molecular diagnostic tests are primarily defined by the volume of blood analysed and by the copy number of the amplified molecular marker serving as the template for amplification. By using mitochondrial DNA as the multi-copy template, the detection limit can be improved more than tenfold, compared to standard 18S rRNA targets, thereby allowing detection of lower parasite densities. In a very low transmission area in Brazil, application of a mitochondrial DNA-based assay increased prevalence from 4.9 to 6.5%. The usefulness of molecular tests in malaria epidemiological studies is widely recognized, especially when precise prevalence rates are desired. Of concern, however, is the challenge of demonstrating test accuracy and quality control for samples with very low parasite densities. In this case, chance effects in template distribution around the detection limit constrain reproducibility. Rigorous assessment of false positive and false negative test results is, therefore, required to prevent over- or under-estimation of parasite prevalence in epidemiological studies or when monitoring interventions UR - https://europepmc.org/articles/PMC5789620 ER -